Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment
Nature Genetics2004Vol. 36(12), pp. 1319–1325
Citations Over TimeTop 1% of 2004 papers
Elisabeth B. Binder, Daria Salyakina, Peter Lichtner, Gabriele M. Wochnik, Marcus Ising, Benno Pütz, Sergi Papiol, Shaun R. Seaman, Susanne Lucae, Martin Kohli, Thomas Nickel, Heike Künzel, B Fuchs, Matthias Majer, Andrea Pfennig, Nikola Kern, Jürgen Brunner, S. Modell, Thomas C. Baghai, Tobias Deiml, Peter Zill, Brigitta Bondy, Rainer Rupprecht, Thomas Messer, Oliver Köhnlein, Heike Dabitz, Tanja Brückl, Nina Müller, Hildegard Pfister, Roselind Lieb, Jakob C. Mueller, Elin Lõhmussaar, Tim M. Strom, Thomas Bettecken, Thomas Meitinger, Manfred Uhr, Theo Rein, Florian Holsboer, Bertram Müller‐Myhsok
Related Papers
- → The role of FKBP5, a co-chaperone of the glucocorticoid receptor in the pathogenesis and therapy of affective and anxiety disorders(2009)949 cited
- → Acute stress enhances heterodimerization and binding of corticosteroid receptors at glucocorticoid target genes in the hippocampus(2016)204 cited
- → Mineralocorticoid receptors dampen glucocorticoid receptor sensitivity to stress via regulation of FKBP5(2021)104 cited
- → Effect of psychosocial stress on FKBP5 and NR3C1 gene expression in healthy young men(2012)1 cited
- → Polymorphisms in the glucocorticoid receptor co-chaperone FKBP5 predict persistent musculoskeletal pain after traumatic stress exposure(2020)